文献速递头颈外科咽喉与嗓音

喉癌治疗延迟对总生存期的影响

Impact of Delay in Treatment Initiation on Overall Survival in Laryngeal Cancers.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-10-16

基于美国国家癌症数据库2006至2014年喉癌患者数据,采用递归分割分析确定治疗延迟时间点,发现延迟超过46天风险增加、超过73天显著影响生存,中位生存期减少16.1个月。

要点

  • 喉癌治疗延迟超过46天风险开始增加,超过73天显著影响生存。
  • 延迟超过73天与中位生存期减少16.1个月相关(P < .001)。
  • 多变量Cox回归证实风险组和延迟组调整后风险比分别为1.09和1.26。

核心结论

  • 喉癌治疗延迟超过46至73天显著影响生存,需识别经历这些延迟的患者。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2006至2014年喉癌患者数据。

主要发现

  • 递归分割分析确定延迟阈值在46天风险显著,73天超过基线风险。
  • 延迟超过73天与中位生存期减少16.1个月相关(P < .001)。

关键数值与推荐

  • 延迟阈值:46天风险显著,73天超过基线风险。
  • 延迟超过73天中位生存期减少16.1个月(P < .001)。

临床怎么用

  • 喉癌治疗需多学科协作,应尽量在46天内启动治疗以避免生存受损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed treatment significantly affects survival in head and neck cancer, but defining delays for specific subsites remains controversial. The purpose of this study is to elicit the time point for delay in treatment initiation in all laryngeal cancers using a large cohort of patients within the National Cancer Database (NCDB). STUDY DESIGN: A retrospective cohort study. SETTING: NCDB. SUBJECTS AND METHODS: Patients with laryngeal cancer within the NCDB from 2006 to 2014 were identified. A recursive partition analysis (RPA) was performed to identify the time point at which delay contributed to increased hazard. Patients were stratified into 3 groups: no delay, at risk, and overtly delayed. Kaplan-Meier method was used to compare overall survival of these cohorts. Multivariate logistic regression analysis was used to identify predictors of delay. A multivariate Cox regression model was used to identify the final covariates that significantly affect overall survival. RESULTS: RPA identified the threshold for delay becomes significant at 46 days and exceeds baseline hazard at 73 days. Delay beyond 73 days is associated with a 16.1-month decrease in median survival ( P < .001). To ensure this was not due to any confounding variables, a subsequent Cox multivariate regression confirmed a significantly increased adjusted hazard ratio (HR) for patients who were at risk or delayed (adjusted HR [confidence interval], 1.09 [1.04-1.15] and 1.26 [1.18-1.35], respectively). CONCLUSION: Treatment of laryngeal cancer requires a multidisciplinary approach, and coordinating this care can take time. Our study highlights that delay beyond 46 to 73 days significantly affects survival and identifies patients experiencing these delays.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Kompelli AR, Li H, Neskey DM, et al. Impact of Delay in Treatment Initiation on Overall Survival in Laryngeal Cancers. Otolaryngol Head Neck Surg. 2018. PMID: 30322343. doi:10.1177/0194599818803330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。